Table 2

Characteristics of patients with rheumatoid arthritis according to disease activity measures.

CDAISDAIDAS28
RemissionLDAMDA + HDAMDA + HDA vs RemissionRemissionLDAMDA + HDAMDA + HDA vs RemissionRemissionLDAMDA + HDAMDA + HDA vs Remission
≤ 2.8> 2.8 and ≤ 10> 10p≤ 3.3> 3.3 and ≤ 11> 11p< 2.6≥ 2.6 and ≤ 3.2> 3.2p
No. patients437131436834782740
Age, yrs, median (IQR)64.1 (55.7–72.6)63.5 (54.0–70.9)60.0 (51.0–65.7)0.0761.7 (53.6–69.2)63.5 (54.0–70.9)60.4 (51.7–68.6)0.5362.4 (53.2–70.4)63.5 (54.4–69.8)61.7 (53.6–72.2)0.91
Sex, female/male30/13 (69.8/30.2)55/17 (76.4/23.6)25/6 (80.6/19.4)0.2931/11 (73.8/26.2)50/18 (73.5/25.5)29/6 (82.9/17.1)0.3455/23 (70.5/29.5)23/5 (82.1/17.9)32/8 (80.0/20.0)0.27
Cardiovascular risk factors
Smoking ever-never27 (62.8)50 (69.4)18 (58.1)0.8125 (59.5)48 (70.6)21 (60.0)0.8454 (69.2)17 (60.7)24 (60.0)0.41
Systolic BP, mm Hg131.3 ± 20.2136.3 ±21.3133.7 ± 18.40.60130.9 ± 20.5134.9 ± 19.8137.1 ± 21.50.20132.1 ± 20.3135.8 ± 18.3137.5 ± 21.80.19
Diastolic BP, mm Hg79.1 ± 10.080.7 ± 9.681.1 ± 9.30.3879.1 ± 9.780.2 ± 10.181.9 ± 8.60.1879.2 ± 10.282.0 ± 9.381.4 ± 8.50.22
Diabetes1 (2.3)8 (11.1)4 (12.9)0.081 (2.4)7 (10.3)5 (14.3)0.066 (7.7)1 (3.6)6 (15.0)0.22
Body mass index, kg/m225.2 ± 3.726.0 ± 5.526.3 ± 4.90.2725.6 ± 4.226.1 ± 5.425.7 ± 4.80.9225.7 ± 4.426.2 ± 6.026.0 ± 5.00.74
Familial CVD6 (14.0)8 (11.1)4 (12.9)0.985 (11.9)9 (13.2)4 (11.4)0.9910 (12.8)3 (10.7)5 (12.5)0.94
CVD measures
CVD3 (7.0)12 (16.7)6 (19.4)0.103 (7.1)11 (16.2)7 (20.0)0.0910 (12.8)2 (7.1)9 (22.5)0.16
Intima-media thickness, mm0.76 ± 0.160.79 ± 0.200.74 ± 0.180.650.77 ± 0.160.78 ± 0.200.76 ± 0.190.920.77 ± 0.170.76 ± 0.170.78 ± 0.220.80
Patients with carotid plaques23 (53.5)49 (68.1)14 (45.2)0.4822 (52.4)45 (66.2)18 (51.4)0.9348 (61.5)15 (53.6)23 (57.5)0.67
No. carotid plaques1.95 ± 0.982.08 ± 0.982.00 ± 1.110.901.86 ± 1.042.04 ± 0.932.17 ± 1.100.381.85 ± 0.902.07 ± 1.032.39 ± 1.080.37
No. GSM plaques Lipids1.94 ± 1.031.92 ± 0.951.83 ± 0.940.782.00 ± 1.131.82 ± 0.801.94 ± 1.120.881.85 ± 0.911.73 ± 0.902.09 ± 1.060.37
Total cholesterol6.1 ± 1.35.7 ± 1.25.2 ± 1.10.0016.1 ± 1.25.7 ± 1.35.3 ± 1.10.0065.8 ± 1.45.79 ± 1.15.47 ± 1.10.22
HDL cholesterol1.8 ± 0.61.8 ± 0.61.7 ± 0.60.381.8 ± 0.61.8 ± 0.61.7 ± 0.50.491.8 ± 0.71.8 ± 0.61.7 ± 0.50.26
Triglycerides, median (IQR)1.1 (0.8–1.5)1.1 (0.8–1.5)1.1 (0.8–1.7)0.661.1 (0.8–1.5)1.1 (0.8–1.5)1.1 (0.8–1.6)0.821.1 (0.7–1.5)1.1 (0.9 –1.5)1.1 (0.7–1.6)0.69
LDL cholesterol3.7 ± 1.03.3 ± 1.02.9 ± 1.00.0013.7 ± 1.13.3 ± 1.03.0 ± 1.10.0053.4 ± 1.13.4 ± 1.03.2 ± 1.00.39
Inflammatory markers
ESR, mm/h, median (IQR)11.0 (6.0–18.0)13.0 (8.0–26.5)13.0 (5.0–26.0)0.4010.0 (6.8–17.0)13.0 (8.0–25.8)17.0 (6.3–29.0)0.039.0 (6.0–14.0)14.0 (8.0–19.5)26.0 (13.5–34.0)< 0.001
CRP, mg/dl, median (IQR)2.0 (1.0–4.0)4.0 (2.0–9.0)4.0 (2.0–11.0)0.0032.0 (1.0–3.3)4.0 (2.0–8.0)7.0 (3.0–21.0)< 0.00013.0 (1.0–4.0)3.0 (1.0–8.0)7.5 (3.3–19.0)< 0.001
  • Demographic data are presented as crude data, compared using Student 2-sample T-test, Mann-Whitney U test, and chi-square test as appropriate. Skewed variables were log-transformed. Median values are given as mean ± SD, numbers (%), skewed data as median with interquartile range (IQR). CDAI: Clinical Disease Activity Index; SDAI: Simplified Disease Activity Index; DAS28: Disease Activity Score based on 28-joint counts; LDA: low disease activity; MDA: moderate disease activity; HDA: high disease activity; BP: blood pressure; CVD: cardiovascular disease; GSM: Gray-Scale Median (lipids are mmol/l); HDL: high-density lipoprotein; LDL: low-density lipoprotein; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.